Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D045744:Cell Line, Tumor; D015870:Gene Expression; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000276:immunology; D016233:Immunotherapy, Active / Q000379:methods*; D015552:Injections, Intralesional; D018664:Interleukin-12 / Q000235:genetics* / Q000276:immunology; D008297:Male; D023421:Models, Animal; D009368:Neoplasm Transplantation; D051381:Rats; D011916:Rats, Inbred F344; D012190:Retroviridae / Q000235:genetics; D013964:Thyroid Neoplasms / Q000276:immunology / Q000628:therapy*; D014161:Transduction, Genetic / Q000379:methods*
D018664:Interleukin-12; D016178:Granulocyte-Macrophage Colony-Stimulating Factor